Cisplatin: best and also substantial SE
Carboplatin: developed to reduce nausea/vomiting, ototoxicity, AKI. SE includes myelosuppression, higher risk of neutropenic fever, hypersensitivity reaction (risk accumulates especially after 8 doses)
Cetuximab: targets regular EGFR that's more frequent in head and neck cancer. Can be used because do not need good kidney function
Figure out where on picture pt falls
No backlinks found.